Literature DB >> 22382802

Exon-level array CGH in a large clinical cohort demonstrates increased sensitivity of diagnostic testing for Mendelian disorders.

Swaroop Aradhya1, Rachel Lewis, Tahrra Bonaga, Nnenna Nwokekeh, Amanda Stafford, Barbara Boggs, Kathleen Hruska, Nizar Smaoui, John G Compton, Gabriele Richard, Sharon Suchy.   

Abstract

PURPOSE: Mendelian disorders are most commonly caused by mutations identifiable by DNA sequencing. Exonic deletions and duplications can go undetected by sequencing, and their frequency in most Mendelian disorders is unknown.
METHODS: We designed an array comparative genomic hybridization (CGH) test with probes in exonic regions of 589 genes. Targeted testing was performed for 219 genes in 3,018 patients. We demonstrate for the first time the utility of exon-level array CGH in a large clinical cohort by testing for 136 autosomal dominant, 53 autosomal recessive, and 30 X-linked disorders.
RESULTS: Overall, 98 deletions and two duplications were identified in 53 genes, corresponding to a detection rate of 3.3%. Approximately 40% of positive findings were deletions of only one or two exons. A high frequency of deletions was observed for several autosomal dominant disorders, with a detection rate of 2.9%. For autosomal recessive disorders, array CGH was usually performed after a single mutation was identified by sequencing. Among 138 individuals tested for recessive disorders, 10.1% had intragenic deletions. For X-linked disorders, 3.5% of 313 patients carried a deletion or duplication.
CONCLUSION: Our results demonstrate that exon-level array CGH provides a robust option for intragenic copy number analysis and should routinely supplement sequence analysis for Mendelian disorders.

Entities:  

Mesh:

Year:  2012        PMID: 22382802     DOI: 10.1038/gim.2011.65

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  24 in total

Review 1.  Evolving health care through personal genomics.

Authors:  Heidi L Rehm
Journal:  Nat Rev Genet       Date:  2017-01-31       Impact factor: 53.242

2.  Eight novel mutations of CBS gene in nine Chinese patients with classical homocystinuria.

Authors:  Dong-Xiao Li; Xi-Yuan Li; Hui Dong; Yu-Peng Liu; Yuan Ding; Jin-Qing Song; Ying Jin; Yao Zhang; Qiao Wang; Yan-Ling Yang
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

Review 3.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

4.  Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome.

Authors:  Simona E Bianconi; Joanna L Cross; Christopher A Wassif; Forbes D Porter
Journal:  Expert Opin Orphan Drugs       Date:  2015-03       Impact factor: 0.694

5.  Assessing copy number from exome sequencing and exome array CGH based on CNV spectrum in a large clinical cohort.

Authors:  Kyle Retterer; Julie Scuffins; Daniel Schmidt; Rachel Lewis; Daniel Pineda-Alvarez; Amanda Stafford; Lindsay Schmidt; Stephanie Warren; Federica Gibellini; Anastasia Kondakova; Amanda Blair; Sherri Bale; Ludmila Matyakhina; Jeanne Meck; Swaroop Aradhya; Eden Haverfield
Journal:  Genet Med       Date:  2014-11-06       Impact factor: 8.822

6.  Array CGH improves detection of mutations in the GALC gene associated with Krabbe disease.

Authors:  Alice K Tanner; Ephrem L H Chin; Patricia K Duffner; Madhuri Hegde
Journal:  Orphanet J Rare Dis       Date:  2012-06-15       Impact factor: 4.123

7.  Whole-Exome Sequencing and Targeted Copy Number Analysis in Primary Ciliary Dyskinesia.

Authors:  Christian R Marshall; Stephen W Scherer; Maimoona A Zariwala; Lynette Lau; Tara A Paton; Tracy Stockley; Rebekah K Jobling; Peter N Ray; Michael R Knowles; David A Hall; Sharon D Dell; Raymond H Kim
Journal:  G3 (Bethesda)       Date:  2015-07-02       Impact factor: 3.154

8.  Copy number analysis of NIPBL in a cohort of 510 patients reveals rare copy number variants and a mosaic deletion.

Authors:  Yu-Wei Cheng; Christopher A Tan; Agata Minor; Kelly Arndt; Latrice Wysinger; Dorothy K Grange; Beth A Kozel; Nathaniel H Robin; Darrel Waggoner; Carrie Fitzpatrick; Soma Das; Daniela Del Gaudio
Journal:  Mol Genet Genomic Med       Date:  2013-11-14       Impact factor: 2.183

9.  New clinical and molecular insights on Barth syndrome.

Authors:  Lorenzo Ferri; Maria Alice Donati; Silvia Funghini; Sabrina Malvagia; Serena Catarzi; Licia Lugli; Luca Ragni; Enrico Bertini; Frédéric M Vaz; David N Cooper; Renzo Guerrini; Amelia Morrone
Journal:  Orphanet J Rare Dis       Date:  2013-02-14       Impact factor: 4.123

10.  The clinical significance of small copy number variants in neurodevelopmental disorders.

Authors:  Reza Asadollahi; Beatrice Oneda; Pascal Joset; Silvia Azzarello-Burri; Deborah Bartholdi; Katharina Steindl; Marie Vincent; Joana Cobilanschi; Heinrich Sticht; Rosa Baldinger; Regina Reissmann; Irene Sudholt; Christian T Thiel; Arif B Ekici; André Reis; Emilia K Bijlsma; Joris Andrieux; Anne Dieux; David FitzPatrick; Susanne Ritter; Alessandra Baumer; Beatrice Latal; Barbara Plecko; Oskar G Jenni; Anita Rauch
Journal:  J Med Genet       Date:  2014-08-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.